Pfizer, Inc. - Hanging in There - I'm on my way OUT
Pfizer is no longer one of the leading Dow 30 - Industrials composite Companies. It is on a Hold, but my (fundamental and technical) Indicators have been breaking down for quite some time just like so many other fine Companies.
Recently it was off its highs by nearly 10% and that is when I get serious. The May rally was pathetic. A bit more upside in June - - I am not impressed
My previously written articles on PFE (just click) provide you the history of my forecasting, its accuracy and support for my performance.
My Performance for Pfizer is about 31% per annum for the last 5 years. (not including dividends).
Look at the Profits for PFE - Over the Years
It is simple, all Companies Cycle from "Favorable" to "Un-Favorable" and in between, they are "Also Rans." This horse-racing metaphor is the best guidance I have to explain how to know the Good / Bad and the Ugly for all securities on the planet.
You might want to have a long look at my current 20 year Chart for Pfizer, it tells you a story about how to make and preserve your profits. Click on PFE. It is not hard to understand how Bear Markets can cause financial set-backs for years and in many cases those set-backs are never recovered. I have over 50 years of successfully doing what I call "preventative maintenance."
I preach "Being Selective" with the "What" and the "When" of investing your money. With this you will become a very profitable Investor. It is my clear answer to being a Consistently Profitable for my Clients.
A Special Note for Seniors & Retired Investors - Dividend Yield - - Pfizer: 3.41%
Forecast w/ 5 Year Performance
Pfizer, Inc. and other Pharmaceutical Companies are tracking the marketplace well. This includes the Health Care Sector which remains selectively very strong.
Note: The below Table is for your review, questions and perhaps thoughts. If you are seeking to "Invest Wisely" in my "Income & Growth" Asset Allocation Model, please email me to open a dialog on how I go about providing superior performance with a very low threshold of risk.
My Current Forecast is not as bright as you may think! (I will be more specific upon your email request).
If you own or are considering owning pharmaceutical companies, the securities are becoming a mixed bag. Pfizer is currently relatively strong technically, but I have reservations about my fundamental valuation; however, it is on my Initial Bearish Forecast - "Warning."
My Current Opinion is to Hold in anticipation of taking profits. This may be at even higher prices, but there will be an end and time to sell, but that is not currently in my forecast. That is a balancing of my below three (weighted) pillars of research.
* Fundamentally - ( weighting - - 40% ): My Analytics for my fundamental valuation play a vital role in profitable managing money. Earnings continue to be only moderate.
* Technically - ( weighting - - 35%): Within this outstanding company, my indicators are not strong enough to be optimistic. It is off its highs of $33, is selling for $30.
* Consensus Opinion - ( weighting - - 25% ): My third pillar of research is one that is always distorted to the positive by most all financial analysts. That's because they are afraid of being bearish.
Here are a number of the Component Companies / Peers in the Pharmaceutical Industry Group that I focus on rather frequently if you wish to follow me: (NYSE:PFE), (NYSE:JNJ), (NYSE:MRK), (NYSE:BMY), (NYSE:ABT), (NYSE:LLY), (NYSE:ABBV), (NYSE:AGN), (NYSE:GSK), (NYSE:AZN), (NYSE:NVS), (NYSE:SNY), (NYSE:NVO). And, more . . .
Note: Should you have interest in my professional guidance and direction for your Portfolios, please Email Me with your questions or thoughts: email@example.com.
For Daily Updates and a Deeper View into my work / Analytics, you might want to Click and Scroll Down to my "Thumb-Nail" Articles within my personal blog.
Please spend some time reading my articles for a perspective of their and also viewing my Bio before making inquiries. Sharing a bit about yourself and your financial and needs, goals and objectives would be appreciated.
A relationship between You and Your Asset Manager must be a "Win / Win" affair. You get the Performance and the Education and I get paid for my Analytics / Work and Experience.
Smile, Have Fun, "Investing Wisely,"
PFE, JNJ, MRK, BMY, ABT, LLY, ABBV, AGN, GSK, AZN, NVS, SNY, NVO